Other Clinical Trial - A Real-world Study of Nitric Oxide Generator &

See also
Status	Clinical Trial	Phase
Terminated	`NCT03132428` - Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension
Enrolling by invitation	`NCT04031508` - Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDH	Phase 2
Completed	`NCT05050045` - Echocardiographic Screening of Healthy Neonates for Measuring Pulmonary Artery Pressure

See also

Status

Clinical Trial

Phase

Terminated

NCT03132428 - Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension

Enrolling by invitation

NCT04031508 - Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDH

Phase 2

Completed

NCT05050045 - Echocardiographic Screening of Healthy Neonates for Measuring Pulmonary Artery Pressure

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05703191
Study type	Observational
Source	Novlead Inc.
Contact	Zhou Fang
Phone	+8615655595707
Email	zhou.fang@novlead.com
Status	Recruiting
Phase
Start date	February 3, 2023
Completion date	May 31, 2023

A Real-world Study of Nitric Oxide Generator and Delivery System

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms